Cidara Therapeutics Inc (CDTX)

Cidara Therapeutics Inc (CDTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Jan 6, 2026: market cap $7B; returns 1 week +0.3%, 1 year +771.9%.

Cidara Therapeutics is a biotechnology company primarily focused on its proprietary Cloudbreak platform, which develops Drug-Fc Conjugates (DFCs) designed to provide long-acting prevention and treatment for serious infections.

CDTX financial model: income statement, cash flow and balance sheet